Descrierea proiectului: Receptorii orfani cuplati cu proteinele G ...

Nature. 1999 Sep 16;401(6750):282-6. Erratum in: Nature 1999 Dec 23-
30;402(6764):898.
2. Behm DJ, Ao Z, Camarda V, Aiyar NV, Johns DG, Douglas SA. Inhibitory
effects of putative peptidic urotensin-II receptor antagonists on urotensin-II-induced
contraction of cat isolated respiratory smooth muscle. Eur J Pharmacol. 2005 Jun
15;516(3):276-81.
3. Brown AJ, Nally JE. Hydrocortisone abolishes the angiotensin II-mediated
potentiation of endothelin-1 in bovine bronchi. Clin Sci (Lond). 2001 Jan;100(1):19-
23.
4. Cazzola M, Noschese P, D'Amato G, Matera MG.The pharmacologic
treatment of uncomplicated arterial hypertension in patients with airway
dysfunction.Chest. 2002 Jan;121(1):230-41.
5. Chen YH, Zhao MW, Yao WZ, Pang YZ, Tang CS. The signal transduction
pathway in the proliferation of airway smooth muscle cells induced by urotensin II.
Chin Med J (Engl). 2004 Jan;117(1):37-41.
6. Douglas SA. Human urotensin-II as a novel cardiovascular target: 'heart' of the
matter or simply a fishy 'tail'? Curr Opin Pharmacol. 2003 Apr;3(2):159-67. Review.
7. Du YC, Xu JY, Zhang SJ. Effects of angiotensin II receptor antagonist on
expression of collagen III, collagen V, and transforming growth factor beta1 in the
airway walls of sensitized rats. Chin Med J (Engl). 2004 Jun;117(6):908-12.
8. Dumitriu I.L., Gurzu B., Slatineanu S.M., Costuleanu M., Petrescu G.
Interactions between angiotensin i and acethylcholine on rat left main bronchial rings.
Rev Med Chi.r Soc Med Nat Iasi 2006: 122 (1): .
9. Gosens R, Schaafsma D, Grootte Bromhaar MM, Vrugt B, Zaagsma J, Meurs
H, Nelemans SA. Growth factor-induced contraction of human bronchial smooth
muscle is Rho-kinase-dependent. Eur J Pharmacol. 2004 Jun 21;494(1):73-6.
10. Goetze JP, Rehfeld JF, Carlsen J, Videbaek R, Andersen CB, Boesgaard S,
Friis-Hansen L. Apelin: a new plasma marker of cardiopulmonary disease. Regul.
Pept. 2006 Jan 15;133(1-3):134-8.
11. Hay DW, Luttmann MA, Douglas SA. Human urotensin-II is a potent
spasmogen of primate airway smooth muscle. Br J Pharmacol. 2000 Sep;131(1):10-2.
12. Hosoya M, Kawamata Y, Fukusumi S, Fujii R, Habata Y, Hinuma S, Kitada C,
Honda S, Kurokawa T, Onda H, Nishimura O, Fujino M. Molecular and functional
characteristics of APJ. Tissue distribution of mRNA and interaction with the
endogenous ligand apelin. J Biol Chem. 2000 Jul 14;275(28):21061-7.
13. Katugampola SD, Maguire JJ, Matthewson SR, Davenport AP. [(125)I]-
(Pyr(1))Apelin-13 is a novel radioligand for localizing the APJ orphan receptor in
human and rat tissues with evidence for a vasoconstrictor role in man.Br J Pharmacol.
2001 Mar;132(6):1255-60.
14. Kishi K, Jin D, Takai S, Muramatsu M, Katayama H, Tamai H, Miyazaki M.
Role of chymase-dependent angiotensin II formation in monocrotaline-induced
pulmonary hypertensive rats. Pediatr Res. 2006 Jul;60(1):77-82.
15. Larsson AK, Back M, Hjoberg J, Dahlen SE. Inhibition of nitric-oxide
synthase enhances antigen-induced contractions and increases release of cysteinylleukotrienes
in guinea pig lung parenchyma: nitric oxide as a protective factor. J
Pharmacol Exp Ther. 2005 Oct;315(1):458-65.
16. Lebed'ko OA, Timoshin SS, Bespalova NN. Effects of angiotensin II on
proliferative activity of epitheliocytes and smooth muscle cells of the
tracheobronchial system in newborn albino rats. Bull Exp Biol Med. 2000
Jul;130(7):636-8.